European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
Top Cited Papers
- 22 February 2019
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 75 (5), 799-810
- https://doi.org/10.1016/j.eururo.2019.02.011
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Pfizer
- Roche
- Bayer
- Sanofi
- Amgen
- Ipsen Biopharmaceuticals
- Bristol-Myers Squibb
- Astellas Pharma
- GlaxoSmithKline
This publication has 72 references indexed in Scilit:
- Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell CarcinomaEuropean Urology, 2018
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018European Journal of Cancer, 2018
- Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of UrologyEuropean Urology, 2017
- Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer RegisterScandinavian Journal of Urology, 2014
- Systematic Review of Adrenalectomy and Lymph Node Dissection in Locally Advanced Renal Cell CarcinomaEuropean Urology, 2013
- Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal CancerEuropean Urology, 2012
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Going from evidence to recommendationsBMJ, 2008
- The changing pattern of kidney cancer incidence and mortality in EuropeBJU International, 2008
- Guidelines on Renal Cell CancerEuropean Urology, 2001